Pancreatic Cyst Dilemmas

From Guidelines to Molecular Markers

Please click play or select a chapter to begin.

Request Information

If you are a physician and would like to learn more about PancraGEN^®, PanDNA^®, or Interpace Diagnostics services, you can reach us using the form below.

I am interested in:

Interest

Learning more about PancraGEN/PanDNA Understanding how to order and use test collection materials Requesting a visit from my representative Other

NPI

(Needed for verification purposes to allow representative follow‑up)

Name

Phone Number

Zip Code

Limitations and Disclaimers¹
Although PancraGEN is highly specific for malignancy, some malignant cysts may not be detected. There may also be individuals who are falsely identified as having a malignant cyst. Diagnosis and appropriate patient management are the responsibility of the referring physician or healthcare provider.

Reference 1. Al-Haddad MA, Kowalski T, Siddiqui A, et al. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy. 2015;47(2):136-142.

Pancreatic Cyst Dilemmas

From Guidelines to Molecular Markers

Webinar Excerpts

Request Information